Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

New Drugs for HDL-C Disorders: The Beginning

Author(s): MyNgan Duong and Stephen J. Nicholls

Volume 21 , Issue 25 , 2014

Page: [2947 - 2951] Pages: 5

DOI: 10.2174/0929867321666140414104130

Price: $65

Abstract

For more than 20 years there has been increasing interest in the development of novel therapies to raise levels of high-density lipoprotein cholesterol (HDL-C). However, well publicized failures of recent clinical trials of agents that raise HDL-C levels have stimulated considerable controversy with regard to the potential clinical utility of this therapeutic target. A number of classes of agents are currently under investigation with variable effects on HDL quantity and quality. These will be reviewed.

Keywords: Atherosclerosis, cardiovascular disease, HDL, lipids, risk factors.


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy